Talking About Glaucoma now has a stand-alone website for my followers to subscribe, leave feedback and support the show. If you help me achieve my first goal, I promise to increase the shows to monthly.
Ep 18 Talking About Glaucoma - The Eye HandBook app (AAC Enhanced)
/In this episode, Dr Krishna and I discuss the Eye HandBook app that he and partner Dr Ken Lord developed. This app, available for both iOS and Android devices, has been a huge success. How can you disagree when the price is FREE and it is loaded with useful information for eye care professionals? At the time of this recording in March 2011 the Android version had yet to be released but it has since been released…see links in the show notes for downloading the iPhone or Android versions.
Read MoreEp 17 Talking About Glaucoma - 10Aug2011: Ologen enhanced Glaucoma Surgery with Steve Sarkisian (AAC Enhanced)
/In this episode, Dr Sarkisian and I discuass his use of Ologen branded collagen matrix in attempts to improve the success of glaucoma surgery. This novel modification has yet to gain widespread support and would still be considered experimental at the time of this recording.
Read MoreEp 16 - Talking About Glaucoma - 26Jul2011 VF progression risk fx with Gus DeMoraes (AAC)
/In this episode, Dr De Moraes and I discuss risk factors for visual field progression in patients already diagnosed with and being treated for glaucoma.
Read MoreEp 15 Talking About Glaucoma - 28Mar2011: Corneal hysteresis & response to PG analogs with Josh Ehrlich (AAC Enhanced)
/In this episode, Dr Ehrlich and I discuss baseline corneal hysteresis and its relationship with the amount of IOP reduction in prostaglandin treatment.
Read MoreEp 14 Talking About Glaucoma - 21Feb2011: New glaucoma devices with Dale Heuer (AAC Enhanced)
/In this episode, Dr Dale Heuer and I discuss the latest glaucoma surgical techniques and devices in search of solid evidence for their safety and effecacy. Trabeculectomy is the operation that we love to hate so we are always looking for something better. In some countries, new devices just require proving safety without having to show efficacy whereas in other countries both must be proven.
Read More